Official ESCRS | European Society of Cataract & Refractive Surgeons
Athens 2016 Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings
ATHENS escrs


Search Abstracts by author or title
(results will display both Free Papers & Poster)

First experience with the KAMRA inlay: is the promise delivered?

Poster Details

First Author: S.Gkorezis GREECE

Co Author(s):                  

Abstract Details


To report the short term efficacy outcomes of our first cases of monocular KAMRA inlay implantation in femtosecond laser-created corneal pockets for surgical compensation of presbyopia.


Epirus Vision Center, Ioannina, Greece


Presbyopic patients between 47 and 54 years old were implanted in the non-dominant eye with KAMRA inlay model ACI 7000 using femtosecond laser-created corneal pockets. Only patients free of ocular pathology with UDVA or CDVA of 6/6 (Snellen) or better and CNVA of J1 in both eyes were eligible. Preoperative and postoperative data included monocular UDVA (Snellen), UNVA (Jaeger), CDVA (Snellen) and CNVA (Jaeger) for the implanted eye in 1 week, 1 month, 3 months and 6 months examination times.


We studied the first 8 cases of Kamra inlay implantation in five male and three male patients. Five of the implanted eyes were right and three were left ones. Mean preop values were UDVA: 6/6, UNVA: J5, CDVA: 6/6 and CNVA: J1. Mean postop values were for the first week UDVA: 6/7.5, UNVA: J2, CDVA: 6/7.5 and CNVA: J2, for the first month UDVA: 6/7, UNVA: J2, CDVA: 6/6 and CNVA: J1, for the third month UDVA: 6/6, UNVA: J2, CDVA: 6/6 and CNVA: J1 and for the sixth month UDVA: 6/7, UNVA: J2, CDVA: 6/6 and CNVA: J1.


Short term efficacy of the procedure seems to be most satisfactory. Increased UNVA in combination with a slightly compromised, if not retained, UDVA in the implanted eye make the KAMRA inlay the best available tool yet, for managing presbyopia safely and effectively. FINANCIAL DISCLOUSRE: NONE

Back to Poster listing